Environmental, Social And Governance Report

Overview

The report describes Royalty Pharma's first materiality assessment and alignment with four Sustainable Development Goals. It reports 75 employees and a 52% female workforce in 2022. Its GHG inventory reports 19,610 MT CO2e from Scope 3 Category 15 investments, while Scope 1 and Scope 2 emissions were absent under the financial-control boundary and the disclosed GHG data received limited assurance from Ernst & Young LLP.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2022
Period: 1 January 2022 – 31 December 2022
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services